Kurt E. Hersberger

4.2k total citations
138 papers, 2.9k citations indexed

About

Kurt E. Hersberger is a scholar working on Geriatrics and Gerontology, Family Practice and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kurt E. Hersberger has authored 138 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Geriatrics and Gerontology, 52 papers in Family Practice and 49 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kurt E. Hersberger's work include Pharmaceutical Practices and Patient Outcomes (59 papers), Medication Adherence and Compliance (52 papers) and Pharmaceutical studies and practices (43 papers). Kurt E. Hersberger is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (59 papers), Medication Adherence and Compliance (52 papers) and Pharmaceutical studies and practices (43 papers). Kurt E. Hersberger collaborates with scholars based in Switzerland, Australia and Canada. Kurt E. Hersberger's co-authors include Isabelle Arnet, Markus L. Lampert, J. W. Foppe van Mil, Markus Messerli, Marion Schaefer, R. Bruppacher, Samuel Allemann, R. Brian Haynes, Mitja Kos and Nejc Horvat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Kurt E. Hersberger

135 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt E. Hersberger Switzerland 27 1.7k 967 632 539 386 138 2.9k
Kay Stewart Australia 35 1.4k 0.8× 722 0.7× 686 1.1× 663 1.2× 789 2.0× 128 4.0k
Ingrid Sketris Canada 29 1.1k 0.7× 399 0.4× 696 1.1× 636 1.2× 568 1.5× 158 3.6k
Emily Hajjar United States 16 2.4k 1.5× 751 0.8× 449 0.7× 1.2k 2.2× 324 0.8× 29 3.5k
Marie‐Laure Laroche France 25 1.8k 1.1× 574 0.6× 380 0.6× 973 1.8× 240 0.6× 92 2.6k
Dale B. Christensen United States 32 1.7k 1.1× 922 1.0× 413 0.7× 830 1.5× 776 2.0× 78 3.3k
Johnson George Australia 37 1.9k 1.2× 1.1k 1.1× 454 0.7× 637 1.2× 1.1k 2.9× 153 4.7k
Caitríona Cahir Ireland 28 1.5k 0.9× 834 0.9× 377 0.6× 922 1.7× 366 0.9× 91 2.5k
Lisa Kalisch Ellett Australia 24 2.1k 1.3× 499 0.5× 373 0.6× 1.0k 1.9× 435 1.1× 113 3.7k
Benoît Allenet France 26 1.2k 0.7× 453 0.5× 335 0.5× 282 0.5× 270 0.7× 119 2.1k
J. Ross Maclean United States 15 1.4k 0.9× 395 0.4× 292 0.5× 816 1.5× 360 0.9× 29 2.7k

Countries citing papers authored by Kurt E. Hersberger

Since Specialization
Citations

This map shows the geographic impact of Kurt E. Hersberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt E. Hersberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt E. Hersberger more than expected).

Fields of papers citing papers by Kurt E. Hersberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt E. Hersberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt E. Hersberger. The network helps show where Kurt E. Hersberger may publish in the future.

Co-authorship network of co-authors of Kurt E. Hersberger

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt E. Hersberger. A scholar is included among the top collaborators of Kurt E. Hersberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt E. Hersberger. Kurt E. Hersberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hersberger, Kurt E., et al.. (2024). Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report. BMC Anesthesiology. 24(1). 416–416. 1 indexed citations
2.
Schwabedissen, Henriette E. Meyer zu, et al.. (2023). Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service. International Journal of Clinical Pharmacy. 45(6). 1378–1386. 4 indexed citations
3.
Schwabedissen, Henriette E. Meyer zu, et al.. (2023). Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report. Pharmacogenomics. 24(14). 739–746. 1 indexed citations
4.
Arnet, Isabelle, et al.. (2023). Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment. European Addiction Research. 29(4). 253–263. 1 indexed citations
5.
Allemann, Samuel, et al.. (2022). Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report. Pharmacogenomics and Personalized Medicine. Volume 15. 465–475. 3 indexed citations
6.
Bodmer, Michael, et al.. (2021). Detection and resolution of drug-related problems at hospital discharge focusing on information availability – a retrospective analysis. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 166. 18–26. 4 indexed citations
7.
Lampert, Markus L., Samuel Allemann, Martin Hatzinger, et al.. (2021). Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial. Trials. 22(1). 919–919. 12 indexed citations
8.
Arnet, Isabelle, Anna Birna Almarsdóttir, Liese Barbier, et al.. (2021). Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey. SHILAP Revista de lepidopterología. 4. 100084–100084. 4 indexed citations
9.
Zeller, Andreas, et al.. (2021). Communicating Electronic Adherence Data to Physicians—Consensus-Based Development of a Compact Reporting Form. International Journal of Environmental Research and Public Health. 18(19). 10264–10264. 3 indexed citations
10.
Lampert, Markus L., et al.. (2021). Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions. Pharmacogenomics and Personalized Medicine. Volume 14. 279–286. 3 indexed citations
11.
Messerli, Markus, et al.. (2020). Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?. SHILAP Revista de lepidopterología. 8(1). 19–19. 7 indexed citations
12.
Albert, Valérie, et al.. (2020). Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact. SHILAP Revista de lepidopterología. 8(1). 36–36. 3 indexed citations
13.
Lampert, Markus L., et al.. (2020). Nonresponse to High-Dose Bupropion for Depression in a Patient Carrying CYP2B6 *6 and CYP2C19 *17 variants: a case report. Pharmacogenomics. 21(16). 1145–1150. 7 indexed citations
14.
Messerli, Markus, Noortje Vriends, & Kurt E. Hersberger. (2018). Humanistic outcomes and patient acceptance of the pharmacist-led medication review “Polymedication Check” in primary care in Switzerland: a prospective randomized controlled trial. Patient Preference and Adherence. Volume 12. 1071–1078. 12 indexed citations
15.
16.
Hersberger, Kurt E., et al.. (2015). Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 5(3). e006376–e006376. 97 indexed citations
17.
Allemann, Samuel, J. W. Foppe van Mil, Lea Botermann, et al.. (2014). Pharmaceutical Care: the PCNE definition 2013. International Journal of Clinical Pharmacy. 36(3). 544–555. 148 indexed citations
18.
Tsakiris, Dimitrios A., et al.. (2013). Antiplatelet resistance in outpatients with monitored adherence. Platelets. 25(7). 532–538. 3 indexed citations
19.
Arnet, Isabelle, et al.. (2012). Pattern of Timing Adherence Could Guide Recommendations for Personalized Intake Schedules. SHILAP Revista de lepidopterología. 2(4). 267–276. 8 indexed citations
20.
Drewe, Jürgen, et al.. (2007). Risk Factors Associated with a High Velocity of the Development of Hyperkalaemia in Hospitalised Patients. Drug Safety. 30(1). 71–80. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kay Stewart Breakdown of academic impact, for papers by Ingrid Sketris Breakdown of academic impact, for papers by Emily Hajjar Breakdown of academic impact, for papers by Marie‐Laure Laroche Breakdown of academic impact, for papers by Dale B. Christensen Breakdown of academic impact, for papers by Johnson George Breakdown of academic impact, for papers by Caitríona Cahir Breakdown of academic impact, for papers by Lisa Kalisch Ellett Breakdown of academic impact, for papers by Benoît Allenet Breakdown of academic impact, for papers by J. Ross Maclean
Rankless by CCL
2026